Posts Tagged: media coverage

BioCentury features Vasomune Therapeutics

Vasomune Therapeutics, a MaRS Innovation start-up company from Sunnybrook Health Sciences Centre's Sunnybrook Research Institute, was featured in a BioCentury emerging company profile by Michael J. Haas. The company is currently raising a Series A financing round and recently closed a seed investment with Genome Canada and an unnamed industry partner. MaRS Innovation also contributed a third of the investment, bringing the round's total to $1.5 million. Haas' profile, "Vasomune: Lassoing Tie2," is available behind a paywall on the BioCentury website. Here's a short ... Read more

Toronto Star features Minuum keyboard’s successful iPhone product launch

UTEST graduate Whirlscape was featured in Raju Mudhar's Toronto Star article, "Toronto’s Whirlscape debuts tiny Minuum keyboard on iPhone," which examines the company's successful launch of their innovative, one-line keyboard for Apple's iOS 8. The UTEST program, co-directed by MaRS Innovation and the University of Toronto's Innovations & Partnerships Office, gives nascent software companies start-up funding, office space, mentoring and business strategy support. Whirlscape was among the program's first cohort. The article was published October 6, 2014. Here's an excerpt: An Indiegogo success 18 ... Read more

Kaypok, MI’s director of intellectual property quoted in the Financial Post

Article focuses on importance of intellectual property protection for small businesses Dr. Stacey Ivanchuk, MaRS Innovation's director of intellectual property, was quoted in Denise Deveau's article, "Intellectual property protection is a game small businesses can't afford to lose," for the Financial Post on September 26, 2014 regarding the importance of protecting intellectual property for small businesses. Here's an excerpt: Stacey Ivanchuk, director of intellectual property for MaRS Innovation in Toronto, says that protecting a startup’s technology is important especially from an investor’s perspective. “One of ... Read more

BioDiaspora founder appears on CBC’s “The National” to discuss the Ebola crisis

Dr. Kamran Khan, founder of BioDiaspora, appeared on CBC's "The National" on September 23, 2014, as part of a health panel examining the current state of the Ebola outbreak in west Africa. CBC anchor Peter Mansbridge hosted the discussion. Watch the clip on CBC's website. BioDiaspora, spun off from St. Michael's Hospital in partnership with MaRS Innovation, developed an easy-to-access, web-based solution that generates and communicates customized, actionable intelligence about global infectious disease threats in real-time. (more…) Read more

WaveCheck campaign part of new study on crowdfunding medical research

MI's Fazila Seker also interviewed in National Post article on what prompts medical researchers to consider crowdfunding The WaveCheck crowdfunding campaign, which raised $53,390 on Indiegogo to support clinical trials for a clinical technique invented by researchers at Sunnybrook Health Sciences Centre and Ryerson University, was included in a new Canadian-led study on the merits of crowdfunding to support cancer and rare diseases. "Crowdfunding drug development: The state of play in oncology and rare diseases," was published in Drug Discovery Today's June issue. MaRS ... Read more

Globe and Mail: Strong incubators are key to driving innovation

Jeff Cates' op-ed in the Globe and Mail's Small Business/Digital Innovation section on June 19, 2014 argues that incubators have a key role to play in fostering innovation, entrepreneurship and growing new industries in Ontario. Cates states this is particularly true when incubators when they provide programs and services to help young entrepreneurs succeed. The University of Toronto Early-Stage Technology program (UTEST), co-managed with MaRS Innovation, is one such program. UTEST is set to announce its third cohort within the next month. (more…) Read more

Frost & Sullivan awards Xagenic award for new product innovation leadership

Market research company lauds start-up for developing a breakthrough workflow while dramatically improving point-of-care diagnosis (MOUNTAIN VIEW, Calif) May 20, 2014 — Based on its recent analysis of the point-of-care diagnostics market, Frost & Sullivan recognizes Xagenic Inc. with the 2014 North America Frost & Sullivan Award for New Product Innovation Leadership. Xagenic’s revolutionary product, the Xagenic X1™ system, is a point-of-care platform with intuitive features to provide lab-free molecular diagnostic testing. It is unique as a low-cost, simple, rapid sample-to-answer desktop instrument, ... Read more

Portfolio snapshot: UTEST in the Wall Street Journal, OtoSim & Sylleta win pitch competitions

Here's a snapshot of some recent portfolio activity: UTEST, the early-stage technology accelerator MI runs in partnership with the University of Toronto, was cited in the Wall Street Journal as part of what makes Toronto the best place to build a start-up in Canada and the eighth-best place in the world. Applications for UTEST's the third cohort are open until Thursday, April 17, 2014. OtoSim Inc. placed first out of 20 companies in the Venture Pitch competition at the Fundica Funding Roadshow for ... Read more

WaveCheck breast cancer technology receives $100,000

OICR's catalyst grant enables WaveCheck to open first partner site at MD Anderson Cancer Center in May TORONTO, April 8, 2014 -- People with breast cancer are a step closer to knowing if their tumour is responding to chemotherapy at the start of treatment, thanks to a $100,000 catalyst grant from the Ontario Institute for Cancer Research (OICR). The funding builds upon MaRS Innovation's Indiegogo crowdfunding campaign for WaveCheck, which successfully raised over $50,000 from over 500 supporters worldwide in two months last ... Read more

Techvibes highlights UTEST’s third cohort

Techvibes, a publication dedicated to covering latest trends in start-up culture and social and mobile news, covered the University of Toronto Early-Stage Technology (UTEST) program's call for applications in an online article on March 1, 2014. Applications for UTEST's third cohort are open until April 17, 2014. Co-directors Kurtis Scissons and Mike Betts will work with selected applicants for a period of twelve months to guide their idea to market. Successful applicants receive work space for a year, mentorship, $30,000 in funding ... Read more
Page 4 of 8« First...23456...Last »